Published October 4, 2016 | Version v1
Patent Open

Recombinant antibodies against H1N1 influenza

Description

Antibodies that bind with high affinity to swine H1N1 virus are described. In vivo experiments showed that one such antibody is able to fully protect mice challenged with a lethal dose of swine H1N1 virus. The antibody is also able to cure mice in a therapeutic setting when treated as late as up to 60 hours (2.5 days) after infection with swine H1N1 virus. Also described are recombinant forms of this antibody.

Files

US9458226.pdf

Files (2.8 MB)

Name Size Download all
md5:4a55295b3845a50202d7c308a7dc19b6
2.8 MB Preview Download

Additional details

Identifiers

Patent number
US 201013393608 A
Patent application number
US 9458226 B2
Other
oai:uchicago.tind.io:9487

Dates

Patent filed
2010-10-12

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Immunology